WeVote

Bill

Bill

HB 1421

Improving Screening for and Treatment of Blood Clots

2025 Regular Session Introduced by Danny Alvarez and 45 co-sponsors

Florida law requires healthcare facilities to implement standardized screening and treatment protocols for blood clots to reduce preventable hospital deaths and complications.

Chapter No. 2025-211
0
WeVote Research Nonpartisan
Bill Summary · HB 1421

Legislative bill overview

HB 1421 establishes new requirements for screening, diagnosis, and treatment protocols for venous thromboembolism (blood clots) in Florida healthcare facilities. The bill mandates training for healthcare providers, requires implementation of evidence-based assessment tools, and creates reporting mechanisms for DVT/PE (deep vein thrombosis/pulmonary embolism) outcomes.

Why is this important

Venous thromboembolism is a leading preventable cause of hospital mortality and morbidity, yet screening and prevention practices remain inconsistent across facilities. Standardizing these protocols could reduce patient harm, improve outcomes, and decrease healthcare costs associated with complications from missed or delayed diagnosis of blood clots.

Potential points of contention

  • Implementation costs: Healthcare facilities may face expenses for staff training, new assessment tools, and protocol development, which could be passed to patients or insurers
  • Regulatory burden: Hospitals must establish new reporting and compliance systems, which smaller facilities may struggle to accommodate
  • Clinical autonomy concerns: Mandated protocols could be viewed as constraining physician judgment in individualized patient care decisions, though protocols are typically evidence-based

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.